おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Adjuvant Capital
company
About
Adjuvant Capital is a life sciences investment firm focused on global health.
- 1 - 10
Highlights
Details
- Industries
- Financial Services,Health Care,Venture Capital
- Founded date
- Jan 1, 2012
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- Venture Capital
Adjuvant Capital is a life sciences investment firm focused on global health. The company makes $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease. Adjuvant Capital was founded in 2012 by Charlie Petty, Glenn Rockman, and Kabeer Aziz and is based in New York.
Investments
Number of Investments
Number of Lead Investments
5
1
Adjuvant Capital has made 5 investments. Their most recent investment was on
Dec 15, 2022, when Minervax raised €22M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 15, 2022
Minervax
|
Series C | €22M | Biotechnology | — |
|
Oct 28, 2022
54gene
|
Convertable Note | $50M | Biotechnology | — |
|
Sep 16, 2021
54gene
|
Series B | $25M | Biotechnology | — |
|
Dec 15, 2020
Minervax
|
Series B | €47.40M | Biotechnology | — |
|
Apr 14, 2020
54gene
|
Series A | $15M | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
